Blog articles


3D render of leukaemia cell

Richter’s syndrome study published

A new study by GEP fellow Niamh Appleby has found potential pathways and targets for the treatment of Richter’s syndrome – an aggressive form of adult leukaemia

Key genomic technologies of 2020: treatments old and new

In the second part of our review of the year’s genomic highlights, we look at the breakthroughs that are helping patients with rare disease and cancer

Genome UK: making the genomic dream a reality

The government has set out its vision for how the UK will harness the power and potential of genomics for the benefit of patients. Here are the top highlights

Genomic approach predicts risk of oesophageal cancer

Can we use genomics to accurately predict the development of cancer in those with precursor conditions? We look at newly published results from a 15-year study to find out

The quadruple helix: a new epigenetic marker?

We all know what DNA looks like, or do we? We take a look at why the quadruple helix can occur and how it could unlock new avenues for cancer therapy

Analysing the epigenome: a new way to screen for cancer

Could the DNA in our bloodstream provide a way to detect cancer? Recent research looks at a novel approach to screening through a new type of blood test

Colibactin and colorectal cancer

A newly published study could mark a major milestone in understanding the microbiome and the role in can play in disease development

We all have 'the breast cancer gene'

You’ve seen the headlines and heard people talk about having ‘the gene for’ x, y or z – but do you know the facts behind the headlines?

News articles


New 'Genomics in Medical Specialties' resources launched

Information for neurology, clinical genetics and gastroenterology has been added to our collection of resources for specialists

Events


Festival of Genomics Logo

Festival of Genomics 2021

The Festival of Genomics London is the UK’s largest genomics event where people from all corners of the genomics industry meet to learn and share expertise.